The role and utility of faecal markers in inflammatory bowel disease
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The role and utility of faecal markers in inflammatory bowel disease
Authors
Keywords
-
Journal
Therapeutic Advances in Gastroenterology
Volume 8, Issue 1, Pages 23-36
Publisher
SAGE Publications
Online
2014-10-14
DOI
10.1177/1756283x14553384
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The intra-individual variability of faecal calprotectin: A prospective study in patients with active ulcerative colitis
- (2014) Anders Lasson et al. Journal of Crohns & Colitis
- The correlation between fecal calprotectin, simple clinical colitis activity index and biochemical markers in ulcerative colitis during high-dose steroid treatment
- (2014) Klaus Theede et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- The long-term outcome of anti-tumor necrosis factor-α therapy related to fecal calprotectin values during induction therapy in pediatric inflammatory bowel disease
- (2014) Kaija-Leena Kolho et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Clinical and histopathological correlations of fecal calprotectin release in colorectal carcinoma
- (2014) Frank Serge Lehmann WORLD JOURNAL OF GASTROENTEROLOGY
- A prospective single-centre evaluation of the intra-individual variability of faecal calprotectin in quiescent Crohn's disease
- (2013) G. D. Naismith et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- The Diagnostic Accuracy of Fecal Calprotectin During the Investigation of Suspected Pediatric Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
- (2013) Paul Henderson et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Fecal Calprotectin More Accurately Reflects Endoscopic Activity of Ulcerative Colitis than the Lichtiger Index, C-reactive Protein, Platelets, Hemoglobin, and Blood Leukocytes
- (2013) Alain M. Schoepfer et al. INFLAMMATORY BOWEL DISEASES
- Neopterin Is a Novel Reliable Fecal Marker as Accurate as Calprotectin for Predicting Endoscopic Disease Activity in Patients with Inflammatory Bowel Diseases
- (2013) Stephane Nancey et al. INFLAMMATORY BOWEL DISEASES
- Fecal Hemoglobin and Calprotectin Are Equally Effective in Identifying Patients with Inflammatory Bowel Disease with Active Endoscopic Inflammation
- (2013) Erik Mooiweer et al. INFLAMMATORY BOWEL DISEASES
- Fecal calprotectin, MMP-9, and human beta-defensin-2 levels in pediatric inflammatory bowel disease
- (2013) Kaija-Leena Kolho et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Optimising monitoring in the management of Crohn's disease: A physician's perspective
- (2013) Pavol Papay et al. Journal of Crohns & Colitis
- A new rapid test for fecal calprotectin predicts endoscopic remission and postoperative recurrence in Crohn's disease
- (2013) Triana Lobatón et al. Journal of Crohns & Colitis
- The Diagnostic Accuracy of Fecal Calprotectin During the Investigation of Suspected Pediatric Inflammatory Bowel Disease
- (2012) Paul Henderson et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Safely ruling out inflammatory bowel disease in children and teenagers without referral for endoscopy
- (2012) Els Van de Vijver et al. ARCHIVES OF DISEASE IN CHILDHOOD
- Value of fecal calprotectin in the evaluation of patients with abdominal discomfort: an observational study
- (2012) Michael Manz et al. BMC GASTROENTEROLOGY
- Monoclonal antibody testing for fecal calprotectin is superior to polyclonal testing of fecal calprotectin and lactoferrin to identify organic intestinal disease in patients with abdominal discomfort
- (2012) Emanuel Burri et al. CLINICA CHIMICA ACTA
- Diagnostic Accuracy of Point-of-Care Fecal Calprotectin and Immunochemical Occult Blood Tests for Diagnosis of Organic Bowel Disease in Primary Care: The Cost-Effectiveness of a Decision Rule for Abdominal Complaints in Primary Care (CEDAR) Study
- (2012) L. Kok et al. CLINICAL CHEMISTRY
- Limitations of Fecal Calprotectin At Diagnosis in Untreated Pediatric Crohnʼs Disease
- (2012) Ron Shaoul et al. INFLAMMATORY BOWEL DISEASES
- Fecal calprotectin concentration predicts outcome in inflammatory bowel disease after induction therapy with TNFα blocking agents
- (2012) Pauliina Molander et al. INFLAMMATORY BOWEL DISEASES
- Fecal calprotectin in predicting relapse of inflammatory bowel diseases: A meta-analysis of prospective studies
- (2012) Ren Mao et al. INFLAMMATORY BOWEL DISEASES
- Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease
- (2012) Geert DʼHaens et al. INFLAMMATORY BOWEL DISEASES
- Fecal MMP-9
- (2012) Anita Annaházi et al. INFLAMMATORY BOWEL DISEASES
- Rapid Test for Fecal Calprotectin Levels in Children With Crohn Disease
- (2012) KL Kolho et al. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
- Maintenance of Remission Among Patients With Crohn's Disease on Antimetabolite Therapy After Infliximab Therapy Is Stopped
- (2011) Edouard Louis et al. GASTROENTEROLOGY
- Results from the 2nd Scientific Workshop of the ECCO (I): Impact of mucosal healing on the course of inflammatory bowel disease
- (2011) Laurent Peyrin-Biroulet et al. Journal of Crohns & Colitis
- Validation of a point-of-care desk top device to quantitate fecal calprotectin and distinguish inflammatory bowel disease from irritable bowel syndrome
- (2011) Michael J. Sydora et al. Journal of Crohns & Colitis
- Fast and sharp decrease in calprotectin predicts remission by infliximab in anti-TNF naïve patients with ulcerative colitis
- (2011) M. De Vos et al. Journal of Crohns & Colitis
- Evaluation of disease activity in IBD at the time of diagnosis by the use of clinical, biochemical, and fecal markers
- (2011) Petr Ricanek et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Fecal calprotectin is equally sensitive in Crohn's disease affecting the small bowel and colon
- (2011) Michael Dam Jensen et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Evaluation of the Quantum Blue(R) rapid test for faecal calprotectin
- (2011) J. Wassell et al. ANNALS OF CLINICAL BIOCHEMISTRY
- Faecal lactoferrin - a novel test to differentiate between the irritable and inflamed bowel?
- (2010) R. SIDHU et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Moderate performance of serum S100A12, in distinguishing inflammatory bowel disease from irritable bowel syndrome
- (2010) Anastassios C Manolakis et al. BMC GASTROENTEROLOGY
- Low-Dose Maintenance Therapy With Infliximab Prevents Postsurgical Recurrence of Crohn's Disease
- (2010) Dario Sorrentino et al. Clinical Gastroenterology and Hepatology
- Faecal calprotectin, lactoferrin, M2-pyruvate kinase and S100A12 in severe ulcerative colitis: a prospective multicentre comparison of predicting outcomes and monitoring response
- (2010) D. Turner et al. GUT
- Diagnostic work-up of inflammatory bowel disease in children: The role of calprotectin assay
- (2010) A. Diamanti et al. INFLAMMATORY BOWEL DISEASES
- Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
- (2010) Jean Frédéric Colombel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Faecal calprotectin in children with clinically quiescent inflammatory bowel disease
- (2010) Taina Sipponen et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Fecal Calprotectin Predicts the Clinical Course of Acute Severe Ulcerative Colitis
- (2009) G T Ho et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Fecal Calprotectin Correlates More Closely With the Simple Endoscopic Score for Crohn's Disease (SES-CD) than CRP, Blood Leukocytes and the CDAI
- (2009) Alain M Schoepfer et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Faecal calprotectin or lactoferrin can identify postoperative recurrence in Crohn's disease
- (2009) C. A. Lamb et al. BRITISH JOURNAL OF SURGERY
- Faecal calprotectin: a noninvasive diagnostic tool and marker of severity in pouchitis
- (2009) Matt W. Johnson et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Monitoring disease activity by stool analyses: from occult blood to molecular markers of intestinal inflammation and damage
- (2009) D Foell et al. GUT
- Questions and answers on the role of fecal lactoferrin as a biological marker in inflammatory bowel disease
- (2009) Javier P. Gisbert et al. INFLAMMATORY BOWEL DISEASES
- Fecal calprotectin mirrors inflammation of the distal ileum and bowel function after restorative proctocolectomy for pediatric-onset ulcerative colitis†
- (2009) Mikko P. Pakarinen et al. INFLAMMATORY BOWEL DISEASES
- Fecal calprotectin variability in Crohnʼs disease
- (2009) Bjrn Moum et al. INFLAMMATORY BOWEL DISEASES
- Does fecal calprotectin predict relapse in patients with Crohn's disease and ulcerative colitis?
- (2009) Valle García-Sánchez et al. Journal of Crohns & Colitis
- Fecal lactoferrin, myeloperoxidase and serum C-reactive are effective biomarkers in the assessment of disease activity and severity in patients with idiopathic ulcerative colitis
- (2009) Ibrahim Masoodi et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Clinical implications of mucosal healing for the management of IBD
- (2009) Guillaume Pineton de Chambrun et al. Nature Reviews Gastroenterology & Hepatology
- Correlation of faecal calprotectin and lactoferrin with an endoscopic score for Crohn’s disease and histological findings
- (2008) T. SIPPONEN et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Can Calprotectin Predict Relapse Risk in Inflammatory Bowel Disease?
- (2008) Renata D'Incà et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Relationships Between Disease Activity and Serum and Fecal Biomarkers in Patients With Crohn's Disease
- (2008) Jennifer Jones et al. Clinical Gastroenterology and Hepatology
- Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease
- (2008) R. Berni Canani et al. DIGESTIVE AND LIVER DISEASE
- Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease
- (2008) J.P. Gisbert et al. DIGESTIVE AND LIVER DISEASE
- Clinical role of calprotectin assay in determining histological relapses in children affected by inflammatory bowel diseases
- (2008) A. Diamanti et al. INFLAMMATORY BOWEL DISEASES
- Fecal calprotectin is useful in predicting disease relapse in pediatric inflammatory bowel disease
- (2008) Dorota Walkiewicz et al. INFLAMMATORY BOWEL DISEASES
- Fecal calprotectin, lactoferrin, and endoscopic disease activity in monitoring anti-TNF-alpha therapy for Crohnʼs disease
- (2008) Taina Sipponen et al. INFLAMMATORY BOWEL DISEASES
- Phagocyte-specific S100 proteins are released from affected mucosa and promote immune responses during inflammatory bowel disease
- (2008) D Foell et al. JOURNAL OF PATHOLOGY
- Noninvasive Markers in the Assessment of Intestinal Inflammation in Inflammatory Bowel Diseases: Performance of Fecal Lactoferrin, Calprotectin, and PMN-Elastase, CRP, and Clinical Indices
- (2007) Jost Langhorst et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- The Assessment of a Rapid Noninvasive Immunochromatographic Assay Test for Fecal Lactoferrin in Patients with Suspected Inflammation of the Ileal Pouch
- (2007) Michael Lim et al. DISEASES OF THE COLON & RECTUM
- Discriminating IBD from IBS: Comparison of the test performance of fecal markers, blood leukocytes, CRP, and IBD antibodies
- (2007) Alain M. Schoepfer et al. INFLAMMATORY BOWEL DISEASES
- Fecal S100A12 and fecal calprotectin as noninvasive markers for inflammatory bowel disease in children
- (2007) Marc A. Sidler et al. INFLAMMATORY BOWEL DISEASES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now